Cite
HARVARD Citation
Pineda, J. et al. (2017). Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection. Clinical microbiology and infection. pp. 409.e5-409.e8. [Online].